凯타민的使用需要在NMDA-R脑炎相关状态发症中谨慎使用
Samhita Panda1, Krishna Kanth Ravi1, Rohit Kushwah1
1Department of Neurology, All India Institute of Medical Sciences, Jodhpur, India.
Journal of epilepsy research
|June 26, 2025
概括
胺可以恶化抗N-甲基-D-酸盐受体 (NMDAR) 脑炎症状,包括超耐火状态 (SRSE). 这种NMDAR抗剂可能会导致性交感性过活,因此在患有NMDAR脑炎的患者中需要谨慎使用.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗N-甲基-D-酸盐受体 (NMDAR) 脑炎涉及降低NMDAR表面密度和突触局部化的抗体.
- 胺,一个NMDAR对手,已知副作用,并已用于超耐火状态 (SRSE).
研究的目的:
- 报告一个抗NMDAR脑炎与超耐火状态 (SRSE) 的病例.
- 为了突出胺在这种特定的临床背景下潜在的不良影响.
主要方法:
- 一个22岁的女性患有抗NMDAR脑炎和SRSE的病例报告.
- 对SRSE进行多种治疗的管理,包括对SRSE的胺.
- 对胺的临床反应和随后的治疗中止的观察.
主要成果:
- 胺的使用导致了临床症状和电图特征的显著恶化.
- 在停止服用胺类药物后,症状有所缓解.
- 患者最终对提欧本输液产生了反应.
结论:
- 矛盾的是,胺使用可能会使抗NMDAR脑炎的临床和电图特征恶化.
- 在患有抗NMDAR脑炎的患者中使用胺或类似的NMDAR作用药物时,建议谨慎使用.
- 这一案例与之前的报道形成鲜明对比,这些报道表明胺在SRSE中有益.
相关概念视频
Parenteral Anesthetics: Overview
211
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
211
Antiepileptic Drugs: Glutamate Antagonists
527
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
527
Antiepileptic Drugs: Potassium Channel Activators
289
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
289
Epilepsy and Seizures: Overview
296
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
296
Antiepileptic Drugs: Calcium Channel Blockers
657
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
657
Depolarizing Blockers: Pharmocokinetics
389
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
389


